Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 7NIH 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia 8Neuroblastoma 7Leukemia, Myeloid, Acute 6Sarcoma 5Leukemia, Myelomonocytic, Acute 5Leukemia, Monocytic, Acute 5Leukemia, Megakaryoblastic, Acute 5Leukemia, Erythroblastic, Acute 5Rhabdomyosarcoma 3Malignant mesenchymal tumor 3Multiple Myeloma 2Ganglioneuroblastoma 2Congenital Abnormalities 2Brain Neoplasms 2Stomach Neoplasms 1Radiation Injuries 1Prostatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Oropharyngeal Neoplasms 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Myelodysplastic Syndromes 1Mouth Neoplasms 1Melanoma 1Medulloblastoma 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1

Interventions

Radiotherapy 38Temozolomide 27Vincristine 15Chemotherapy, Adjuvant 11Carboplatin 11Filgrastim 10Granulocyte Colony-Stimulating Factor 9Etoposide 9Cyclophosphamide 9Lomustine 8Carmustine 7Cisplatin 6Peripheral Blood Stem Cell Transplantation 5etoposide phosphate 4Thiotepa 4Radiotherapy, Intensity-Modulated 4Radiotherapy, Conformal 4Procarbazine 4Neoadjuvant Therapy 4Irinotecan 4Immunohistochemistry 4Gene Expression Profiling 4Topotecan 3Radiosurgery 3Radiation 3lonafarnib 2Psychiatric Rehabilitation 2Microarray Analysis 2Methotrexate 2Mesna 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Central Nervous System Neoplasms × sargramostim × Clear all
NCT00002594 2014-07-24

Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors

Children's Oncology Group

Phase 2 Completed
31 enrolled
CNS

Brain Neoplasms, Medulloblastoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡